TABLE 1—
Subject Characteristics at Baseline, Medians and IQR Reported for Continuous Variables, Number and Percent Reported for Categorical Variables
| All (N = 80) | Male (n = 43) | Female (n = 37) | |
|---|---|---|---|
| Age | 12 (9.0, 14.5) | 11.1 (8.5, 14.7) | 12.4 (9.3, 14.5) |
| Race | |||
| White | 76 (95) | 41 (95) | 35 (95) |
| African American | 2 (2.5) | 2 (5) | 0 (0) |
| Unknown/missing | 2 (2.5) | 0 (0) | 2 (5) |
| Pancreatic insufficient | 68 (85) | 38 (88) | 30 (81) |
| CF mutation | |||
| DeltaF508 homozygous | 37 (46) | 25 (58) | 12 (32) |
| DeltaF508 heterozygous | 25 (31) | 8 (19) | 17 (46) |
| Other | 18 (23) | 10 (23) | 8 (22) |
| BMI percentile | 59 (35, 74) | 58 (36, 71) | 60 (34, 79) |
| FEV1% predicted | 93 (84, 110) | 93 (84, 110) | 93 (82, 112) |
| Outcome | |||
| Completed study period | 55 (69) | 28 (65) | 27 (73) |
| Lost to follow-up | 11 (14) | 7 (16) | 4 (11) |
| Developed CFRD | 12 (15) | 6 (14) | 6 (16) |
| Late entry1 | 2 (2) | 2 (5) | 0 (0) |
| Follow-up time (years) | 4.8 (4.1, 5.0) | 4.7 (4.0, 5.0) | 4.9 (4.2, 5.0) |
1
Study entry later than September 2008.